Management of angina pectoris.
Rinaldi R, Kunadian V, Crea F, Montone RA.
Trends Cardiovasc Med. 2025 Aug;35(6):341-350. doi: 10.1016/j.tcm.2025.03.001. Epub 2025 Mar 12.
Mixed angina pectoris.
Maseri A, Chierchia S, Kaski JC.
Am J Cardiol. 1985 Sep 18;56(9):30E-33E. doi: 10.1016/0002-9149(85)91173-7.
[Mixed angina pectoris].
Kato K, Yasutake M.
Nihon Rinsho. 2007 Sep 28;Suppl 5 Pt 2:117-20.
[Mixed angina pectoris].
Yasutake M.
Ryoikibetsu Shokogun Shirizu. 1996;(12):654-6.
Calcium Channel Blockers.
[No authors listed]
2017 Jan 11. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus JA, Jones PG, Maron DJ, O'Brien SM, Reynolds HR, Rosenberg Y, Stone GW, Harrell FE Jr, Boden WE, Weintraub WS, Baloch K, Mavromatis K, Diaz A, Gosselin G, Newman JD, Mavromichalis S, Alexander KP, Cohen DJ, Bangalore S, Hochman JS, Mark DB; ISCHEMIA Research Group.
N Engl J Med. 2020 Apr 9;382(15):1408-1419. doi: 10.1056/NEJMoa1916370. Epub 2020 Mar 30.
Cognitive Decline Before and After Incident Coronary Events.
Xie W, Zheng F, Yan L, Zhong B.
J Am Coll Cardiol. 2019 Jun 25;73(24):3041-3050. doi: 10.1016/j.jacc.2019.04.019.
[Angina pectoris revisited].
Stejfa M.
Vnitr Lek. 1991 Jan;37(1):6-12.
Nifedipine and angina pectoris. Short-term changes in quantitative coronary angiography with nifedipine and clinical response to treatment in effort-induced, mixed, and spontaneous angina pectoris.
De Cesare N, Bartorelli A, Fabbiocchi F, Loaldi A, Montorsi P, Polese A, Guazzi MD.
Chest. 1988 Mar;93(3):485-92. doi: 10.1378/chest.93.3.485.
Clinical pharmacokinetics of labetalol.
McNeil JJ, Louis WJ.
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
